Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Molino

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Seminars in Surgical Oncology|January 1, 1988
Recombinant alpha-interferon and vinblastine in metastatic renal cell carcinoma: efficacy of low dosesG L Cetto, T Franceschi, G Turrina, et al.
Biochimica Et Biophysica Acta|February 5, 2000
CXCR4 on human endothelial cells can serve as both a mediator of biological responses and as a receptor for HIV-2M Molino, M J Woolkalis, N Prevost, et al.
Future Oncology (London, England)|February 25, 2015
Observational study on adjuvant trastuzumab in HER2-positive early breast cancer patientsG Mustacchi, F Puglisi, A M Molino, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Seminars in Surgical Oncology|January 1, 1988
Recombinant alpha-interferon and vinblastine in metastatic renal cell carcinoma: efficacy of low dosesG L Cetto, T Franceschi, G Turrina, et al.
Biochimica Et Biophysica Acta|February 5, 2000
CXCR4 on human endothelial cells can serve as both a mediator of biological responses and as a receptor for HIV-2M Molino, M J Woolkalis, N Prevost, et al.
Future Oncology (London, England)|February 25, 2015
Observational study on adjuvant trastuzumab in HER2-positive early breast cancer patientsG Mustacchi, F Puglisi, A M Molino, et al.
Pageof 5